Matthew B. Klein - 14 May 2024 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
Director
Signature
/s/ Richard F. Mattern, by Power of Attorney for Matthew B. Klein
Issuer symbol
CLPT
Transactions as of
14 May 2024
Transactions value $
$0
Form type
4
Filing time
15 May 2024, 09:19:14 UTC
Previous filing
22 Apr 2024
Next filing
17 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLPT Common Stock Options Exercise +17.2K +139.77% 29.4K 14 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLPT Restricted Stock Units Options Exercise $0 -17.2K -100% $0.00* 0 14 May 2024 Common Stock 17.2K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.